Fluticasone Propionate Nasal Spray
Brand names: Flixonase, Pirinase (OTC)
Fluticasone propionate nasal spray is an intranasal corticosteroid used to control the symptoms of allergic and non-allergic rhinitis.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Applied topically to the nasal mucosa, it exerts potent local anti-inflammatory glucocorticoid activity, reducing inflammatory mediators and mucosal oedema with minimal systemic absorption.
Prescribing in practice
- Local effects such as epistaxis, nasal dryness and, rarely, nasal septal perforation can occur, so correct away-from-the-septum spray technique should be advised.
- It works prophylactically and needs regular daily use, with full benefit taking several days to develop rather than giving immediate relief.
- Prolonged high-dose intranasal corticosteroid use warrants awareness of potential systemic effects, particularly with concurrent inhaled or oral steroids.
Monitoring
Monitor symptom control and inspect for local nasal adverse effects such as bleeding or crusting at review.
Counselling the patient
- Use it every day as prescribed even when you feel well, as it prevents rather than instantly relieves symptoms.
- Aim the nozzle slightly away from the middle wall of the nose and avoid sniffing hard.
- Report persistent nosebleeds or nasal discomfort.
Evidence & guidelines
Intranasal corticosteroids are the most effective treatment for moderate-to-severe allergic rhinitis and are recommended first-line in NICE and ARIA guidance.
Reference: NICE NG174 Allergic Rhinitis; BAO-HNS Rhinitis Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020